Page last updated: 2024-08-24

norharman and lazabemide

norharman has been researched along with lazabemide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Oh, SR; Park, D; Ryu, HW1
Asensio, VJ; Esteban, S; GarcĂ­a-Sevilla, JA; Miralles, A; Moranta, D; Sastre-Coll, A1

Other Studies

2 other study(ies) available for norharman and lazabemide

ArticleYear
Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
    Bioorganic & medicinal chemistry letters, 2018, 08-01, Volume: 28, Issue:14

    Topics: Benzophenanthridines; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship

2018
High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    European journal of pharmacology, 2005, Aug-22, Volume: 518, Issue:2-3

    Topics: Animals; Benzofurans; Binding, Competitive; Brain; Carbolines; Cerebral Cortex; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Harmine; Hippocampus; Imidazoles; Imidazoline Receptors; Liver; Male; Monoamine Oxidase; Morphine; Morphine Dependence; Naloxone; Norepinephrine; Picolinic Acids; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Drug; Substance Withdrawal Syndrome; Thiazoles; Tritium; Tyrosine 3-Monooxygenase

2005